NTLA Intellia Therapeutics, Inc.
Healthcare$12.44+0.00%OpenMarket Cap: $1.40B
As of 2026-05-26
Insider Statistics (Q1 2026)
Acquisitions
14
Dispositions
9
Buy/Sell Ratio
1.56
Net Shares
+861,332
Shares Acquired
946,987
Shares Disposed
85,655
Total Bought ($)
$1.00
Total Sold ($)
$9.00
Recent Insider Trades
| Filing Date | Name | Type | Action | Shares | Price | Shares After |
|---|---|---|---|---|---|---|
| Tue Mar 03 | Schultes Birgit C | officer: EVP, Chief Scientific Officer | Sell | 39,200 | $0.00 | 137,733 |
| Tue Mar 03 | LEONARD JOHN M | director, officer: President and CEO | Sell | 225,400 | $13.78 | 225,400 |
| Tue Mar 03 | LEONARD JOHN M | director, officer: President and CEO | Sell | 156,400 | $0.00 | 1,169,739 |
| Tue Mar 03 | Lebwohl David | officer: EVP, Chief Medical Officer | Sell | 14,204 | $13.78 | 14,204 |
| Tue Mar 03 | Lebwohl David | officer: EVP, Chief Medical Officer | Sell | 9,943 | $0.00 | 131,192 |
| Tue Mar 03 | Dulac Edward J III | officer: EVP, Chief Financial Officer | Sell | 87,543 | $13.78 | 87,543 |
| Tue Mar 03 | Dulac Edward J III | officer: EVP, Chief Financial Officer | Sell | 61,280 | $0.00 | 160,963 |
| Tue Mar 03 | BASTA JAMES | officer: EVP, General Counsel | Sell | 1,211 | $13.78 | 156,794 |
| Tue Mar 03 | BASTA JAMES | officer: EVP, General Counsel | Sell | 65,829 | $13.78 | 65,829 |
| Tue Mar 03 | BASTA JAMES | officer: EVP, General Counsel | Sell | 46,080 | $0.00 | 158,005 |